WO1997001355A1 - Excitation de substances naturelles induite par voie magnetique ou electromagnetique - Google Patents

Excitation de substances naturelles induite par voie magnetique ou electromagnetique Download PDF

Info

Publication number
WO1997001355A1
WO1997001355A1 PCT/IT1996/000125 IT9600125W WO9701355A1 WO 1997001355 A1 WO1997001355 A1 WO 1997001355A1 IT 9600125 W IT9600125 W IT 9600125W WO 9701355 A1 WO9701355 A1 WO 9701355A1
Authority
WO
WIPO (PCT)
Prior art keywords
substances
natural
magnetic field
magnetic
derivatives
Prior art date
Application number
PCT/IT1996/000125
Other languages
English (en)
Inventor
Antonio Sacchetti
Original Assignee
Antonio Sacchetti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antonio Sacchetti filed Critical Antonio Sacchetti
Priority to AU62406/96A priority Critical patent/AU6240696A/en
Publication of WO1997001355A1 publication Critical patent/WO1997001355A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood

Definitions

  • the present invention relates to the field of the homeopa ⁇ thy, homotoxicology, and the treatments by means of food integrators, and more particularly a method of energizing natural substances by electromagnetic fields .
  • the result of the described phenomenon is the in ⁇ creased probability of ionization with relative increase of the exchanges and then the dynamic activity (B. Brandi- marte, La Sapienza University of Rome) .
  • one object of the invention is of increasing the activity of natural therapeutic products by energizing such substances to bring them to the state that they had in the living plants without resorting to the mechanical shaking used in homeopathy.
  • Another object of the invention is of resorting to the in- fluence of a magnetic field on biological products for re ⁇ activating the same.
  • the intensity of such a force is measured in DinaHerg (in the following, so-called DH) , where one DH corresponds to the magnetization acquired by a substance which is exposed to a magnetic field of 150 Gauss for one hour.
  • DH DinaHerg
  • the magnetic field can be applied to any therapeutic, alimentary or cosmetic substance, and that magnetic fields of any intensity may be applied.
  • Fig. 1 shows schematically a substance which is subjected to a magnetic field produced by a coil
  • Fig. 2 shows schematically a substance which is subjected to a magnetic field produced by a permanent magnet.
  • magnetism induces magnetism to any neigh ⁇ bouring body and that the magnetism is a quantifiable energy which is easily transmitted.
  • Another basic feature of the magnetism is that such a form of energization is in accordance with the natural phenomenon and the molecular biology.
  • mag ⁇ netic dipoles Fe, Co, Ni
  • some other substances are heavy to be magnetized because con ⁇ flicting forces are acting therein.
  • the magnetization induced through immersion into an artificial magnetic field may infuse energy both by fixed polarization which keeps the polari- zation of the dipoles unchanged, and by alternate polari ⁇ zation which infuses a high energy without orienting the dipoles of the body, i.e. without creating a morphological unbalance in the matter subjected to the electromagnetic induction. It is evident that the alternate magnetic energization in ⁇ fuses energy without orienting (magnetizing) the therapeu ⁇ tic substance. This allows energy at high level to be in ⁇ fused into the matter without changing the inherent quality of the same, unlike the mechanical shaking which infuses energy affecting the electromagnetic balance be ⁇ longing to that particular substance.
  • the better intensity of the magnetic field proposed by the experimentations is about 150 Gauss which energizes the living and biological tissues without altering them.
  • one Dina- Herg is the magnetism to which a body is subjected when it is exposed to a magnetic field of 150 Gauss for one hour.
  • the lat ⁇ ter is infused with that energy and magnetism which will be lost in the next manipulations, i.e. warm or cold breaking, micronization, drying, grinding, heating, shaking, extraction, etc.).
  • any particle or molecule has its own electromagnetic energy which gives it a specific "character" contributing along with that of the other particles to form the characteristics of the plant or phytoterapic element. Accordingly, the operator has an instrument for modulating also the characteristics of the phytoterapic element as a whole by modulating such electromagnetic energy.
  • the reason is to be seen in that we human beings are made of biological matter and have our own mag ⁇ netism which could affect or change the effectiveness of the drugs. Therefore, according to the invention there are provided special protecting packages capable of keep the energizing characteristics of the preparations unchanged.
  • the method of strengthening the therapeutic activity of the present invention includes the following steps:
  • an electromagnetically energized vitamin C is much more active than a synthetic one. It should be appreciated that, for example, a food integrator of today cannot include more than 60 mg vitamin C which corresponds to 100% RAD (daily advised dose) according to the sanitary rules in force.
  • vitamin C may reach a dose of 1 g.
  • most of vitamin C administered by mouth is not absorbed by the body which assumes the needed quantity.
  • administering a 8 DH vitamin C stands for assuming a vitamin which has absorbed a field of 1200 Gauss, i.e. a considerable energy capable of increasing the biological disposability and activity also in little doses.

Landscapes

  • Health & Medical Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procédé de renforcement de l'activité thérapeutique de substances naturelles et de leurs dérivés, selon lequel on excite par voie magnétique les substances naturelles en soumettant, pendant une durée déterminée, de telles substances naturelles et notamment biologiques à l'action d'un champ magnétique continu ou pulsé dont l'intensité est telle qu'il ne provoque aucun effet de chauffage ou de dénaturation au sein des substances traitées, puis on conditionne les substances ainsi obtenues dans des emballages étanches aptes à assurer leur intégrité et leur protection contre les secousses et les champs magnétiques externes, afin que les caractéristiques d'excitation électromagnétique acquises au cours du traitement magnétique demeurent inaltérées.
PCT/IT1996/000125 1995-06-26 1996-06-21 Excitation de substances naturelles induite par voie magnetique ou electromagnetique WO1997001355A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU62406/96A AU6240696A (en) 1995-06-26 1996-06-21 Magnetic or electromagnetically induced energization of natural substances

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM95A000433 1995-06-26
IT95RM000433A IT1290779B1 (it) 1995-06-26 1995-06-26 Procedimento per il potenziamento delle attivita' terapeutiche di sostanze naturali (vitamine, minerali, erbe, fitopreparati, alimenti)

Publications (1)

Publication Number Publication Date
WO1997001355A1 true WO1997001355A1 (fr) 1997-01-16

Family

ID=11403447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT1996/000125 WO1997001355A1 (fr) 1995-06-26 1996-06-21 Excitation de substances naturelles induite par voie magnetique ou electromagnetique

Country Status (3)

Country Link
AU (1) AU6240696A (fr)
IT (1) IT1290779B1 (fr)
WO (1) WO1997001355A1 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024115A1 (fr) * 1997-11-11 1999-05-20 Scalarmind, S.L. Procede et appareil permettant de transferer des informations d'une premiere substance a une deuxieme substance, et plaque antiparasitaire
FR2780651A1 (fr) * 1998-07-01 2000-01-07 Digibio Procede pour activer une solution inactive et a tres faible concentration d'une subsdeterminee biologique et/ou chimique dans un solvant
WO2000078349A1 (fr) * 1999-06-18 2000-12-28 Pascal Berdal Procede pour l'obtention de produits ayant des effets benefiques
FR2800575A1 (fr) * 1999-11-08 2001-05-11 Pascal Berdal Procede pour preparer des aliments et des complements alimentaires ayant des effets sur la sante
WO2002004067A1 (fr) * 2000-07-12 2002-01-17 Digibio Procede et dispositif pour eviter l'alteration d'une substance ayant des activites biologiques
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
US11072625B2 (en) 2016-10-07 2021-07-27 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR946061A (fr) * 1947-05-03 1949-05-23 Formation, sous l'action de champs électro-magnétiques, d'anti-virus ou bactériophages de micro-organismes pathogènes
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
DE3634121A1 (de) * 1986-05-09 1987-11-12 Otto Kausch Verfahren und einrichtung zur verbesserung der wirkungen fluessiger oder pastoeser praeparate
EP0326143A1 (fr) * 1988-01-28 1989-08-02 Bernhard Müller Procédé pour le traitement des substances dans un champ magnétique
WO1989009049A1 (fr) * 1988-04-01 1989-10-05 Walter Whitson Fischman Preparations pharmaceutiques homeopathiques magnetiquement influencees, leurs procedes de preparation et d'administration
DE3839852A1 (de) * 1988-11-25 1990-05-31 Magnet Activ Vertrieb Von Biol Verfahren und vorrichtung zur elektromagnetischen beeinflussung von fluessigen, elektrisch leitenden substanzen
WO1992019320A1 (fr) * 1991-05-07 1992-11-12 Whitson Fischman Walter Formulations pharmaceutiques homeopathiques sous influence magnetique

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR946061A (fr) * 1947-05-03 1949-05-23 Formation, sous l'action de champs électro-magnétiques, d'anti-virus ou bactériophages de micro-organismes pathogènes
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
DE3634121A1 (de) * 1986-05-09 1987-11-12 Otto Kausch Verfahren und einrichtung zur verbesserung der wirkungen fluessiger oder pastoeser praeparate
EP0326143A1 (fr) * 1988-01-28 1989-08-02 Bernhard Müller Procédé pour le traitement des substances dans un champ magnétique
WO1989009049A1 (fr) * 1988-04-01 1989-10-05 Walter Whitson Fischman Preparations pharmaceutiques homeopathiques magnetiquement influencees, leurs procedes de preparation et d'administration
DE3839852A1 (de) * 1988-11-25 1990-05-31 Magnet Activ Vertrieb Von Biol Verfahren und vorrichtung zur elektromagnetischen beeinflussung von fluessigen, elektrisch leitenden substanzen
WO1992019320A1 (fr) * 1991-05-07 1992-11-12 Whitson Fischman Walter Formulations pharmaceutiques homeopathiques sous influence magnetique

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024115A1 (fr) * 1997-11-11 1999-05-20 Scalarmind, S.L. Procede et appareil permettant de transferer des informations d'une premiere substance a une deuxieme substance, et plaque antiparasitaire
FR2780651A1 (fr) * 1998-07-01 2000-01-07 Digibio Procede pour activer une solution inactive et a tres faible concentration d'une subsdeterminee biologique et/ou chimique dans un solvant
WO2000001412A1 (fr) * 1998-07-01 2000-01-13 Digibio Procede pour activer une solution inactive
WO2000078349A1 (fr) * 1999-06-18 2000-12-28 Pascal Berdal Procede pour l'obtention de produits ayant des effets benefiques
FR2800575A1 (fr) * 1999-11-08 2001-05-11 Pascal Berdal Procede pour preparer des aliments et des complements alimentaires ayant des effets sur la sante
FR2811591A1 (fr) * 2000-07-12 2002-01-18 Digibio Procede et dispositif pour eviter l'alteration d'une subtance ayant des activites biologiques
WO2002004067A1 (fr) * 2000-07-12 2002-01-17 Digibio Procede et dispositif pour eviter l'alteration d'une substance ayant des activites biologiques
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11072625B2 (en) 2016-10-07 2021-07-27 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
US11780873B2 (en) 2016-10-07 2023-10-10 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Also Published As

Publication number Publication date
ITRM950433A0 (it) 1995-06-26
ITRM950433A1 (it) 1996-12-26
AU6240696A (en) 1997-01-30
IT1290779B1 (it) 1998-12-10

Similar Documents

Publication Publication Date Title
US4106488A (en) Cancer treatment method
RU2141855C1 (ru) Магнитотерапия и физиотерапевтическое устройство со сканирующим магнитным полем
WO1997001355A1 (fr) Excitation de substances naturelles induite par voie magnetique ou electromagnetique
Yanase et al. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes
US7179217B2 (en) Apparatus for enhancing tissue repair in mammals
US20030093028A1 (en) Appararus and method for magnetic induction of therapeutic electric fields
Babincová et al. Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field
Häfeli et al. Modeling of magnetic bandages for drug targeting: Button vs. Halbach arrays
CA2383465A1 (fr) Dispositif a but therapeutique sur les tissus humains, destine a influencer des particules magnetiques injectees au moyen d'un champ electromagnetique alternatif a gradient
US5827170A (en) Therapeutic magnetic vortex ornament and device
JP2010516705A (ja) 温熱療法におけるサセプタとその使用法
US7611453B2 (en) Apparatus and method for static magnetic field treatment of tissue, organs, cells, and molecules
US5984855A (en) Magnetic blanket for horses
Janković et al. Magnetic fields, brain and immunity: effect on humoral and cell-mediated immune responses
US6669623B1 (en) Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
Barth et al. Depression of interferon production in mice after treatment with anti-lymphocyte serum
DE2828941C2 (fr)
RU2099080C1 (ru) Способ предотвращения развития рака
Markov Therapeutic application of static magnetic fields
CA1334936C (fr) Formulations homeopathiques magnetiques, methodes pour leur preparation et pour leur administration
Kato et al. Preparation and characterization of ferromagnetic mitomycin C microcapsules as a means of magnetic control of anticancer drugs
RU2155081C1 (ru) Способ обработки вещества магнитным полем и устройство для его осуществления
Ives et al. Energy medicine
Strojan et al. Combined radiation and chemotherapy for advanced undifferentiated nasopharyngeal carcinoma in children
Mahaley Jr et al. New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA